Clinical Trials Logo

QTc Intervals Changes clinical trials

View clinical trials related to QTc Intervals Changes.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04175808 Completed - Clinical trials for QTc Intervals Changes

Study to Assess the Effect of Omecamtiv Mecarbil (OM) on QT/QTc Intervals in Healthy Adults

Start date: November 14, 2019
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to assess the effect of a single therapeutic (50 mg) oral dose of omecamtiv mecarbil (OM) on the QT interval / QT interval corrected for heart rate (QTc), relative to placebo, in healthy adults. The QT interval is the section on an electrocardiogram (ECG) that represents the time it takes for the electrical system to fire an impulse through the ventricles and then recharge, or the time it takes for the heart muscle to contract and then recover.